MedX Health Corp's stock has remained stable this week amidst notable developments in its business strategy.
This week, MedX Health Corp (MDX.V) has seen its shares close at C$0.05, reflecting no change in price from the previous trading day. The stock has experienced a modest increase of 11.11% over the past month, although it remains down 9.09% year-to-date. This stability comes on the heels of recent company news that may impact its future trajectory.
Advertisement
MedX Health Corp
MDX.V
MDX.V
MedX Health Corp
WealthAwesomeMarket cap
$16.40M
52W high
$0.07
52W low
$0.04
1W change
+0.00%
Beta
1.76
Analyst Price Targets
Based on analyst covering MDX · as of Sep 17, 2026
Wall Street analysts forecast MDX stock price to rise 460.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.28
+460.0% Upside
Current Price
C$0.05
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MDX's historical volatility
30-Day Vol
115.0%
Annualized
90-Day Vol
103.5%
Annualized
Trend (90d)
-0.0%
Annualized drift
90d Mean
C$0.05
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.05 | C$0.03 – C$0.07 |
| 60 trading days | C$0.05 | C$0.03 – C$0.09 |
| 90 trading days | C$0.05 | C$0.03 – C$0.10 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: MedX Health's appointment of Monaderm as a representative for its SkinSecure™ product line in Europe could open new avenues for growth in the beauty and aesthetics sector. Investors may want to monitor how this partnership develops and its potential impact on revenue.
C$0.28 Average Analyst Target
Analysts have set an average target of C$0.28 for MedX, suggesting a significant upside from its current trading price, indicating bullish sentiment based on future growth potential.
Bull case
The appointment of Monaderm could strengthen MedX's presence in Europe, potentially boosting sales and enhancing brand recognition in the beauty and aesthetics market.
Bear case
Despite these opportunities, MedX's current financials show challenges, including a profit margin of 0.0% and a negative EPS. Investors should be cautious about the company's ability to turn new partnerships into profitability.
Recent Company News
Advertisement
On October 5, 2026, MedX Health Corp announced the appointment of Monaderm as a representative for its SkinSecure™ product line across Europe. This partnership focuses on beauty and aesthetics research, which may provide MedX with opportunities to expand its market presence and drive revenue growth in the European market.
Technical Picture
Currently, MedX Health Corp's stock is trading at C$0.05, which is at the lower end of its 52-week range of C$0.04 to C$0.07, representing approximately 33% of that range. The stock is below its 50-day moving average of C$0.05, which is down 4.2% from the current price, and also below the 200-day moving average of C$0.06, down 12.0%. With a beta of 1.76, the stock exhibits higher volatility compared to the market. The latest trading volume of 44,400 shares is below the 20-day average volume of 56,578 shares, indicating reduced trading activity.
Price Action
MedX Health Corp's last closing price was C$0.05, with no change observed over the last trading day. The stock has shown a modest gain of 11.11% over the past month, reflecting a slow but steady recovery in the context of its year-to-date performance.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
